Angiotensin II receptor type 1 blockade decreases CTGF/CCN2-mediated damage and fibrosis in normal and dystrophic skeletal muscles

dc.contributor.authorCabello Verrugio, Claudio Alejandro
dc.contributor.authorMorales France, María Gabriela
dc.contributor.authorVio Lagos, Carlos P.
dc.contributor.authorBrandan, Enrique
dc.date.accessioned2016-05-10T18:10:52Z
dc.date.available2016-05-10T18:10:52Z
dc.date.issued2012
dc.identifier.doi10.1111/j.1582-4934.2011.01354.x
dc.identifier.issn1582-1838
dc.identifier.urihttps://repositorio.uc.cl/handle/11534/13004
dc.identifier.urihttps://doi.org/10.1111/j.1582-4934.2011.01354.x
dc.language.isoen
dc.relation.isformatofJournal of Cellular and Molecular Medicine No. 4 (16), p. 752-764.
dc.revistaJournal of Cellular and Molecular Medicinees_ES
dc.subject.ddc610
dc.subject.deweyMedicina y saludes_ES
dc.subject.otherFibrosises_ES
dc.subject.otherTejido conectivoes_ES
dc.subject.otherMúsculo esqueléticoes_ES
dc.titleAngiotensin II receptor type 1 blockade decreases CTGF/CCN2-mediated damage and fibrosis in normal and dystrophic skeletal muscleses_ES
dc.typeartículo
sipa.codpersvinculados134336
sipa.codpersvinculados4922
sipa.codpersvinculados99575
sipa.codpersvinculados52075
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Angiotensin II receptor type 1 blockade decreases CTGFCCN2-mediated damage and fibrosis in normal and dystrophic skeletal muscles.pdf
Size:
1010 KB
Format:
Adobe Portable Document Format
Description: